Sort
15,842 grants matching “pancreatic cancer”
Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathway
$200,318Rudi Fasan · University Of Rochester · R21 · FY2015 · CA
Discovery of allele-selective KRAS inhibitors
$200,310Brent R Stockwell · Columbia Univ New York Morningside · R21 · FY2014 · CA
Tumor-TAMs crosstalk enables bypass of oncogenic KRAS dependency in pancreatic cancer
$200,281Pingping Hou · Rutgers Biomedical And Health Sciences · K22 · FY2023 · CA
Tumor-TAMs crosstalk enables bypass of oncogenic KRAS dependency in pancreatic cancer
$200,281Pingping Hou · Rbhs-New Jersey Medical School · K22 · FY2022 · CA
Tumor-TAMs crosstalk enables bypass of oncogenic KRAS dependency in pancreatic cancer
$200,281Pingping Hou · Rutgers Biomedical And Health Sciences · K22 · FY2024 · CA
Sleeping Beauty Mediated Therapy for Alpha V Beta 6-Expressing Pancreatic Cancer
$200,244Kendra A. Hyland · Discovery Genomics, Inc. · R43 · FY2013 · CA
CORE--CELL BANK/IMMUNOLOGY
$200,139Columbia University Health Sciences · P30 · FY2004 · DK
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
$200,107Hyun-Sung Lee · Baylor College Of Medicine · R21 · FY2024 · AI
Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection
$200,060Katharina Schlacher · Sloan-Kettering Inst Can Research · K22 · FY2013 · CA
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
$200,031Aaron Grossberg · Oregon Health & Science University · K08 · FY2024 · CA
1/2: "Feasibility Studies to Build Collaborative Partnerships in Reducing Racial/Ethnic Disparities in GI Cancer Research" Minority Supplement 1
$200,001Ellen Li · State University New York Stony Brook · P20 · FY2016 · CA
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$200,000Christopher Horvath · Intica Biomedical, Inc. · N43 · FY2012 · CA
DEVELOPMENT OF A RAPID IN VITRO SCREENING ASSAY FOR DETECTION OF CANCER BIOMARKE
$200,000Frank Kroh · Nanoscale Materials, Inc. · N43 · FY2011 · CA
Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer
$200,000Paras N. Prasad · State University Of New York At Buffalo · R01 · FY2009 · CA
Engineering and targeting novel antigen-specific tolerogenic interfaces
$200,000Remi J Creusot · Columbia University Health Sciences · R21 · FY2016 · AI
SPORE in Gastrointestinal Cancer
$200,000Scott E Kern · Johns Hopkins University · P50 · FY2006 · CA
Novel small molecule agents to correct pathogenic VHL missense mutations
$200,000Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
$200,000Evan L Fogel · Indiana University Indianapolis · U01 · FY2024 · DK
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$200,000Terence Marques Williams · Ohio State University · R01 · FY2016 · CA
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
$200,000Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2016 · CA
Refolding Mutant p53: A Strategy for Cancer Prevention in Li-Fraumeni Syndrome
$200,000Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA
Phase 1 Study of ABC294640 for the Treatment of Pancreatic Cancer
$200,000Lynn W Maines · Apogee Biotechnology Corporation · R01 · FY2012 · FD
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
$200,000Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2016 · CA
University of Colorado Cancer Center Support Grant
$199,999Richard D Schulick · University Of Colorado Denver · P30 · FY2019 · CA
Oxidative stress-induced cellular servival pathways in pancreatic cancer
$199,998Nathan Robert Wall · Loma Linda University · P20 · FY2007 · MD